At the time of writing, CureVac N.V. [CVAC] stock is trading at $3.44, up 11.33%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CVAC shares have gain 25.55% over the last week, with a monthly amount glided 3.93%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CureVac N.V. [NASDAQ: CVAC] stock has seen the most recent analyst activity on April 25, 2024, when Leerink Partners downgraded its rating to a Market Perform and also revised its price target to $4 from $12. Previously, SVB Securities started tracking the stock with Outperform rating on June 08, 2023, and set its price target to $13. On January 19, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $18 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $21 on January 09, 2023. BofA Securities downgraded its rating to a Underperform and reduced its price target to $20 on January 21, 2022. JMP Securities started tracking with a Mkt Outperform rating for this stock on January 18, 2022, and assigned it a price target of $52. In a note dated October 22, 2021, Deutsche Bank initiated an Hold rating and provided a target price of $35 on this stock.
For the past year, the stock price of CureVac N.V. fluctuated between $2.21 and $8.33. Currently, Wall Street analysts expect the stock to reach $29 within the next 12 months. CureVac N.V. [NASDAQ: CVAC] shares were valued at $3.44 at the most recent close of the market. An investor can expect a potential return of 743.02% based on the average CVAC price forecast.
Analyzing the CVAC fundamentals
According to CureVac N.V. [NASDAQ:CVAC], the company’s sales were 71.17M for trailing twelve months, which represents an 88.41% jump. Gross Profit Margin for this corporation currently stands at -1.62% with Operating Profit Margin at -4.47%, Pretax Profit Margin comes in at -4.2%, and Net Profit Margin reading is -4.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.57 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.16 points at the first support level, and at 2.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.58, and for the 2nd resistance point, it is at 3.72.
Ratios To Look Out For
It is important to note that CureVac N.V. [NASDAQ:CVAC] has a current ratio of 2.29. As well, the Quick Ratio is 2.28, while the Cash Ratio is 1.84. Considering the valuation of this stock, the price to sales ratio is 10.84, the price to book ratio is 1.91.
